These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36112582)

  • 1. Longitudinal study of the immune response and memory following natural bovine respiratory syncytial virus infections in cattle of different age.
    Hägglund S; Näslund K; Svensson A; Lefverman C; Enül H; Pascal L; Siltenius J; Holzhauer M; Delabouglise A; Österberg J; Alvåsen K; Olsson U; Eléouët JF; Riffault S; Taylor G; Rodriguez MJ; Garcia Duran M; Valarcher JF
    PLoS One; 2022; 17(9):e0274332. PubMed ID: 36112582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus infections in human beings and in cattle.
    Van der Poel WH; Brand A; Kramps JA; Van Oirschot JT
    J Infect; 1994 Sep; 29(2):215-28. PubMed ID: 7806887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies.
    Kimman TG; Westenbrink F; Schreuder BE; Straver PJ
    J Clin Microbiol; 1987 Jun; 25(6):1097-106. PubMed ID: 2954996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.
    Blodörn K; Hägglund S; Fix J; Dubuquoy C; Makabi-Panzu B; Thom M; Karlsson P; Roque JL; Karlstam E; Pringle J; Eléouët JF; Riffault S; Taylor G; Valarcher JF
    PLoS One; 2014; 9(6):e100392. PubMed ID: 24945377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine respiratory syncytial virus ISCOMs-Immunity, protection and safety in young conventional calves.
    Hägglund S; Hu K; Vargmar K; Poré L; Olofson AS; Blodörn K; Anderson J; Ahooghalandari P; Pringle J; Taylor G; Valarcher JF
    Vaccine; 2011 Nov; 29(47):8719-30. PubMed ID: 21864616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.
    McGill JL; Kelly SM; Kumar P; Speckhart S; Haughney SL; Henningson J; Narasimhan B; Sacco RE
    Sci Rep; 2018 Feb; 8(1):3021. PubMed ID: 29445124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine model of respiratory syncytial virus infection.
    Taylor G
    Curr Top Microbiol Immunol; 2013; 372():327-45. PubMed ID: 24362697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves.
    Ellis JA; Gow SP; Mahan S; Leyh R
    J Am Vet Med Assoc; 2013 Dec; 243(11):1602-8. PubMed ID: 24261811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody.
    Kolb EA; Buterbaugh RE; Rinehart CL; Ensley D; Perry GA; Abdelsalam KW; Chase CCL
    Vaccine; 2020 Jan; 38(2):298-308. PubMed ID: 31668818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of bovine respiratory syncytial virus infections: a longitudinal epidemiological study in dairy herds.
    Van der Poel WH; Kramps JA; Middel WG; Van Oirschot JT; Brand A
    Arch Virol; 1993; 133(3-4):309-21. PubMed ID: 8257292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
    Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
    J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.
    Díaz FE; Guerra-Maupome M; McDonald PO; Rivera-Pérez D; Kalergis AM; McGill JL
    Front Immunol; 2021; 12():664212. PubMed ID: 33981309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody dynamics in BRSV-infected Danish dairy herds as determined by isotype-specific immunoglobulins.
    Uttenthal A; Larsen LE; Philipsen JS; Tjørnehøj K; Viuff B; Nielsen KH; Nielsen TK
    Vet Microbiol; 2000 Oct; 76(4):329-41. PubMed ID: 11000530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with a mucosal, post-fusion F/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection.
    Maina TW; Grego EA; Broderick S; Sacco RE; Narasimhan B; McGill JL
    Front Immunol; 2023; 14():1186184. PubMed ID: 37359514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of bovine respiratory syncytial virus infections in young dairy and beef cattle in Poland.
    Urban-Chmiel R; Wernicki A; Puchalski A; Dec M; Stęgierska D; Grooms DL; Barbu NI
    Vet Q; 2015 Mar; 35(1):33-6. PubMed ID: 25365424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a DRB3*011:01-restricted CD4
    Kaplan BS; Hofstetter AR; McGill JL; Lippolis JD; Norimine J; Dassanayake RP; Sacco RE
    Front Immunol; 2023; 14():1040075. PubMed ID: 36891302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine respiratory syncytial virus in experimentally exposed and rechallenged calves; viral shedding related to clinical signs and the potential for transmission.
    Klem TB; Sjurseth SK; Sviland S; Gjerset B; Myrmel M; Stokstad M
    BMC Vet Res; 2019 May; 15(1):156. PubMed ID: 31109324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions.
    Taylor G; Thomas LH; Furze JM; Cook RS; Wyld SG; Lerch R; Hardy R; Wertz GW
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3195-206. PubMed ID: 9400970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
    Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
    Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine.
    Schreiber P; Matheise JP; Dessy F; Heimann M; Letesson JJ; Coppe P; Collard A
    J Vet Med B Infect Dis Vet Public Health; 2000 Sep; 47(7):535-50. PubMed ID: 11048435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.